Cas No.: | |
Chemical Name: | 4-(3-(2-(4-(cyano(phenyl)methylene)piperidin-1-yl)-2-oxoacetyl)-4-methoxy-1H-pyrrolo[2,3-c]pyridin-7-yl)-N-(2-hydroxyethyl)thiazole-2-carboxamide |
Synonyms: | BMS818251;BMS 818251 |
SMILES: | S1C=C(C2=NC=C(OC)C3C(C(C(N4CC/C(=C(\C#N)/C5=CC=CC=C5)/CC4)=O)=O)=CNC2=3)N=C1C(NCCO)=O |
Formula: | C29H26N6O5S |
M.Wt: | 570.624 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | BMS-818251 (BMS818251) is a novel potent, small-molecule inhibitor of HIV-1 entry with EC50 of 0.019 nM against e laboratory-adapted HIV-1 strain NL4-3; displays >10-fold more potent than temsavir on a cross-clade panel of 208-HIV-1 strains, interacts with gp120 residues from the conserved β20-β21 hairpin to improve potency. |